Iskander Andrew, Gan Tong J
Department of Anesthesiology, Stony Brook University, Stony Brook, New York, USA.
Curr Opin Anaesthesiol. 2018 Dec;31(6):685-692. doi: 10.1097/ACO.0000000000000665.
The increasing number of procedures done in the ambulatory surgical setting necessitates the need for analgesic modalities that enable the management of postsurgical pain with fast onset, predictable duration of action, and minimal need for management of undesirable side-effects.
The novel strategies for administration of local anesthetics in the ambulatory setting include prolonging their analgesic action at the site of surgical trauma while reducing systemic effects that result from their metabolism. Development of opioids aims to address receptor sites that provide for modulation of pain perception while reducing systemic, central effects of μ-receptor agonism. Other, more titratable agents with analgesic properties are also addressed.
Local anesthetics, opioids, and NSAIDS are the mainstay of multimodal analgesic management, and as such, improving their efficacy in the ambulatory surgical setting remains the primary focus. However, as knowledge of the modulating pathways involved in transduction of pain increases, newer agents that utilize this knowledge are also becoming more widely available.
门诊手术中进行的手术数量不断增加,因此需要采用能够快速起效、作用持续时间可预测且很少需要处理不良副作用的镇痛方式来管理术后疼痛。
门诊环境中局部麻醉药给药的新策略包括延长其在手术创伤部位的镇痛作用,同时减少因代谢产生的全身效应。阿片类药物的研发旨在针对那些能够调节疼痛感知的受体位点,同时减少μ受体激动所产生的全身及中枢效应。还讨论了其他具有镇痛特性且更易于滴定的药物。
局部麻醉药、阿片类药物和非甾体抗炎药是多模式镇痛管理的主要药物,因此,提高它们在门诊手术环境中的疗效仍然是主要关注点。然而,随着对疼痛传导中调节途径的认识不断增加,利用这一知识的新型药物也越来越广泛地可用。